Winnipeg woman seeks rare cancer trial in Texas
Cynthia Mitchell of Winnipeg fights cholangiocarcinoma, a rare bile duct cancer, and is seeking access to a clinical trial in Texas. Diagnosed in 2021, she remains determined in her battle.
Cynthia Mitchell of Winnipeg fights cholangiocarcinoma, a rare bile duct cancer, and is seeking access to a clinical trial in Texas. Diagnosed in 2021, she remains determined in her battle.
New data shows Eli Lilly's oral weight-loss drug successfully maintains weight reduction after patients switch from injectable medications. A breakthrough for chronic obesity management.
The B.C. government has released new clinical guidance for physicians to improve mental health and substance-use care for young people across the province. Learn about the key changes.
Halifax's IWK Health is set to launch the new One Person One Record clinical information system this weekend, aiming to streamline patient data for healthcare professionals.
Novo Nordisk, maker of Wegovy, plans clinical trials for its experimental obesity medication CagriSema in overweight children and adolescents. Get the latest details on this significant development in pediatric health.
China's biopharma industry is accelerating, fueled by record investment and streamlined supply chains. With faster development times and massive deals like AstraZeneca's $5.2B pact, the global drug innovation race is heating up. Discover the shift from ou
Edmonton's Cross Cancer Institute leads a revolutionary immunotherapy approach, achieving 52% remission rates while slashing treatment costs by 90%. Discover how local research transforms cancer care.
Bioethicist Marie-Josée Potvin warns Quebec's Bill 2 destroys patient-clinician trust by imposing political targets in medical decisions. Read why healthcare professionals are protesting.
Danish pharmaceutical giant Novo Nordisk faces major setback as Alzheimer's drug trials fail. Learn how this impacts the weight-loss leader's expansion plans.
Experienced health leaders are being replaced by political appointees across Canada, risking universal healthcare. Learn how this shift from expertise to ideology puts patient care in jeopardy.
New data reveals cholera infections across Africa have reached three times higher than officially reported in 2022. Learn about the ongoing crisis and vaccine development efforts.
SPRI and Neuromuscular Dynamics launch NIH-funded clinical trial testing Leg Dexterity System for non-surgical knee osteoarthritis treatment. Eight-week study aims to reduce pain and improve mobility.
YPrime research reveals AI-powered workflows reduce eCOA localization errors by 74% and speed review cycles by 67%, enabling faster, more inclusive global clinical trials for Canadian research.
Université de Montréal rector Daniel Jutras argues that university expertise is crucial for tackling global crises from climate change to AI, despite public skepticism about higher education.
Eupraxia Pharmaceuticals reveals consistent 52-week data from RESOLVE trial, showing EP-104GI maintains clinical remission in eosinophilic esophagitis patients with strong safety profile.
A new online platform helps Canadian cancer patients discover available clinical trials. Learn how this resource could transform cancer care access across the country.
Nova Scotia's Premier Tim Houston makes strategic Calgary visit to attract oil and gas expertise for massive offshore wind and green hydrogen development, positioning the province as Canada's next clean energy frontier.
YPrime launches groundbreaking eCOA oversight technology that transforms clinical trial monitoring, ensuring investigator accountability and participant protection in real-time.